Navigation Links
CCPM Issues Statement on FDA's GIVE Initiative
Date:10/4/2007

WASHINGTON, Oct. 5 /PRNewswire-USNewswire/ -- The Coalition for a Competitive Pharmaceutical Market (CCPM) issued the following statement today on the Food and Drug Administration's announcement regarding its "Generic Initiative for Value and Efficiency" (GIVE):

"With consumers, employers, insurers, and policymakers grappling with how to manage escalating prescription drug costs, it is critical that FDA and Congress continue to focus on ways to enhance timely generic access. Today's announcement of the GIVE program by FDA helps focus attention on the need to bolster the generic drug program, but real work remains on important issues that are hindering consumer access. To achieve this, FDA and Congress must address existing issues including the lack of a workable approval pathway for biogenerics, increased funding for the Office of Generic Drugs (OGD) and stopping brand-name pharmaceutical companies from unfairly extending brand drug patents.

"As momentum grows for access to biogenerics, it is imperative that Congress provide FDA with a clear process for facilitating the development and approval of these life-saving medicines that would give patients affordable alternatives to the brand drugs they need. Regulatory and administrative actions are also needed to restructure OGD programs to ensure timely generic access.

"Finally, insufficient OGD funding is slowing the process of getting generic drugs to market. While we welcome FDA's statement that it will hire and train new generic drug reviewers, sufficient funding is needed to make this wish a reality. Substantially increasing resources for OGD is critical to increasing competition in the pharmaceutical market and getting generics into the hands of consumers. We applaud the Senate and House members of the Appropriations Committees for recognizing the importance of sufficient funding and we hope this needed increase is included in the final legislation."

CCPM is an organization of large
'/>"/>

SOURCE CCPM
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Stabilizing RNA in Fresh and Frozen Tissues for RNA Isolation
2. Genomic DNA Preparation from RNAlater Preserved Tissues
3. Preparation of PCR Quality Template DNA from a Wide Range of Tissues Using InstaGene Matrix
4. Using the VersaFluor Fluorometer to Quantitate GUS Expression in Plant Tissues Bombarded With the Biolistic PDS-1000/He System
5. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
6. Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data
7. Evaluation of RNA isolated from human tissues: quality control for surgical and postmortem samples
8. Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA)
9. Inline intellectual property raises legal issues
10. SC Johnson issues trademark warning over web offer
11. Company issues warning on outsourced software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...all/--IES(Nasdaq: IESC ),aleadingnationalprovidero...hecommercial,industrialandresidentialmarkets,annou...dedacontractfromManhattanTorconJVtoinstalltheelect...ementfacilityattheU.S.ArmyMedicalResearchInstitute...rick,Md. ,, ThenewUSAMRIIDreplacementfacilitywi...
(Date:11/24/2009)...ewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: D...NasdaqStockMarketthattradinginthecompany,scommonst...SEwillbefiledwiththe,SecuritiesandExchangeCommissi...nNasdaq,unlessthecompanyfilesanappealtotheNasdaq,L...appeal,which,willstaythesuspensionanddelistingthro...
(Date:11/24/2009)...e-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abioph...lizingnovelpainmanagementtherapies,announcedtodayt...r,isscheduledtopresentatthe21stAnnualPiperJaffrayH...ewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTon...availabletorespondtoquestionsduringthepresentation...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-...ofadvancedlasersystemsandinstrumentsforthestemcell...rationalandfinancialresultsforthethirdquarterended...s$1.46millioncomparedwith$1.43millioninQ32008,-Gro...tinQ3,2008,-Netlossreducedto$148,000comparedto$283...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...igma-Aldrich Corporation,(Nasdaq: SIAL ), will ho...,quarter results on Wednesday, July 23, 2008, at 1...his call is being webcast by Thomson/CCBN and can .../www.sigma-aldrich.com ., The webcast is also be...etwork to both institutional and individual invest...
... Following First-in-Man study success, Ovalum...™ technology in the coronary arteries. Ovalu...mpany, has announced today successful experiences ...aversing chronic total occlusions in the coronary ...ael (PRWEB) July 11, 2008 -- Following First-in-Ma...
...ewswire-FirstCall/ - ARIUS Research Inc., (TSX:,AR...ping the next wave of,antibody therapeutics, today...or the second fiscal quarter of 2008, ended May 31...ntained our focus on moving,ARIUS, anti-cancer ant...,our lead drug candidates received significant att...
Other Biology Technology:Sigma-Aldrich Corporation's 2nd Quarter 2008 Earnings Conference Call 2Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire 2ARIUS announces second quarter fiscal 2008 financial results 2ARIUS announces second quarter fiscal 2008 financial results 3ARIUS announces second quarter fiscal 2008 financial results 4ARIUS announces second quarter fiscal 2008 financial results 5ARIUS announces second quarter fiscal 2008 financial results 6ARIUS announces second quarter fiscal 2008 financial results 7ARIUS announces second quarter fiscal 2008 financial results 8ARIUS announces second quarter fiscal 2008 financial results 9ARIUS announces second quarter fiscal 2008 financial results 10ARIUS announces second quarter fiscal 2008 financial results 11ARIUS announces second quarter fiscal 2008 financial results 12ARIUS announces second quarter fiscal 2008 financial results 13ARIUS announces second quarter fiscal 2008 financial results 14ARIUS announces second quarter fiscal 2008 financial results 15
(Date:11/24/2009)...9) -- The Wildlife Conservation Society (WCS) anno...ning population of Siberian tigers has likely decl...ing and habitat loss. , WCS says the... needs to be done to protect remaining populations...report was released by the Siberian Tiger Monitori...
(Date:11/23/2009)...dence that the "synergistic" effect of early-life ... and indoor endotoxin causes more harm to developi..., Environmental health scientists at the Universi...wn that children exposed to both high levels of tr...g early life are six times more likely to experien...
(Date:11/23/2009)...ts gathered this week for the seventh annual Natio...This year,s topic, "Synthetic Biology," brought to...ers to explore the engineering, scientific, and so...hetic biology. , Bonnie L. Bassler, professor of...s year,s conference chair, challenged the attendee...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 1MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 2MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 3MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 4MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 5OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 1OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 2OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 3TorreyPines Receives Notice of Delisting from Nasdaq Global Market 13095 1TorreyPines Receives Notice of Delisting from Nasdaq Global Market 13095 2
... Whether or not a fertilized mammalian egg ultimat...y the winner of a tug of war between two different...nt pathways they control, according to a new study...ists. , In their experiments in mice, the research...are in equal balance in the early stages of develo...
... A gene that is associated with osteoarthritis and...be responsible for preventing the onset of osteoar... led by Rhode Island Hospital. The matrilin-3 gene...bone mineral density in adulthood and prevents ost...in-3 have previously been linked to certain skelet...
... Most women at high risk for breast cancer do not ...tamoxifen, according to a new analysis by research...rgh and McMaster University in Ontario, Canada. In...s an extraordinarily expensive cancer-prevention s...of life saved. The study will be published in the ...
Other Biology News:Genetic tug of war determines sexual differentiation 2Genetic tug of war determines sexual differentiation 3Matrilin-3 gene discovered to prevent onset of osteoarthritis 2Matrilin-3 gene discovered to prevent onset of osteoarthritis 3Tamoxifen for breast cancer prevention does not benefit most women 2Tamoxifen for breast cancer prevention does not benefit most women 3
Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)
Goat Anti-Human SorCS1 Polyclonal Antibody, Unconjugated from R&D Systems
Goat Anti-Human PLUNC Polyclonal Antibody, Biotin Conjugated from R&D Systems
Mouse Anti-Human RXR beta / NR2B2 Monoclonal Antibody, Unconjugated, Clone H7341 from R&D Systems
Biology Products: